2022-2029 年全球疫苗恆温箱市场

市场概览

在预测期内（2022-2029 年），全球疫苗恆温箱市场规模预计将以 7.0% 的复合年增长率增长。

疫苗在运输过程中使用冷藏箱和小型抗体转运蛋白保持低温。 等温箱是冷箱和免疫载体的超集。 免疫转运蛋白与冷藏箱具有相似的特性，只是它们的体积较小。

疫苗恆温箱市场可以根据材料细分为聚氨酯、聚丙烯、聚乙烯、聚苯乙烯等。 一种用途广泛的材料类型是聚氨酯。 聚氨酯泡沫是通过多元醇和二异氰酸酯反应生产的。 等温填料是在高密度聚氨酯泡沫上形成两层氧化铝，并用足够的力将它们粘合在一起，以达到优异的硬度。

另外，在疫苗领域，有远距离和近距离等温箱。 远距离等温疫苗容器有两种尺寸：5-15 升和 15-25 升。 疫苗领域的短程等温箱分为15和25升、5和15升、5升以下。

市场动态

对到达疫苗最后一英里的经济型冷链解决方案的需求不断增长，这推动了恆温器的发展。

对能够实现疫苗最后一英里交付的经济型冷链解决方案的需求不断增长，这推动了恆温容器的发展。

疫苗是全球健康和发展领域最重要的成就之一。 两个多世纪以来，疫苗成功地减少了小儿麻痹症、麻疹和天花等疾病的肆虐，让孩子们健康快乐地成长。 据联合国儿童基金会称，甚至在 COVID-19 到来之前，它每分钟就挽救了 5 条以上的生命，每年避免 300 万人死亡。

全球免疫工作使儿童能够行走、玩耍和学习。 接种疫苗的儿童在学校表现更好，从而为他们的社区带来经济利益。 疫苗现在被认为是改善全球福利的最具成本效益的方法之一。

但是，最后一英里的疫苗供应不足和不合格是对公众健康的最大威胁之一。 据联合国儿童基金会称，每年约有 2000 万儿童无法获得拯救生命的疫苗。 在许多情况下，需要疫苗的最贫困和最边缘化的儿童获得疫苗的可能性最小。 联合国儿童基金会及其合作伙伴正在使用太阳能、移动技术和遥测技术来确保每个孩子都接种了疫苗，而不是因为极端的高温或寒冷而变得无效。。

装有疫苗（尤其是抗体转运蛋白）□□的恆温箱足够小，一个健康专家可以通过车辆或步行将其运送到工作地点。 此外，等温抗体还可以将疫苗接种从基本医疗场所转移到过渡性疫苗接种商店。

库存网络管理不当制约疫苗恆温箱市场

全球疫苗恆温箱市场预计将受到供应链管理不善的阻碍。 冷却液包使用不当和恆温器选择错误都是管理不善的例子。 诸多困难阻碍了冷链物流管理。

儘管需求量很大，但很少有物流供应商能够应对交付高度管制的药品（例如等温疫苗）的挑战。 例如，在美国，78% 的冷藏仓库已超过 20 年，已经过时，无法满足现代运营需求。

车辆管理效率低下也是必须解决的问题之一。 冰箱和车辆经常出故障。 订购额外的零件和执行日常维护会减慢操作速度。 同时，由于冷链无法跟踪车辆移动，装运可能会延迟，进口货物可能会在入境口岸等待很长时间。

此外，运输需要精确温度和湿度条件的原材料成本很高。 然而，在可见性和管理有限的情况下，即使是运输环境的微小变化也可能导致巨大的损失。 特别是当涉及到昂贵的药物时，风险更大。

如果供应链没有保持在适当的温度范围内，疫苗接种的有效性可能会受到影响，尤其是对于昂贵的药物。 目前正在努力将等温包装商业化以防止结冰。

COVID-19 影响分析

COVID-19 大流行带来的全球健康危机推动了对用于对抗 SARS-CoV-2 病毒的恆温疫苗运输箱的需求。 所有热敏疫苗都使用主动或被动冷製造方法控制储存温度范围，但早期的 COVID-19 疫苗需要在 -90 至 -60°C 之间储存和运输。我有。

传统的 -25/-15°C 范围内的共晶板无法满足此温度要求，因为它们的熔点不接近 -70°C。 干冰在 78.5°C 时的昇华焓为 573 kJ.kg-1 (25,2 kJ.mol-1)，是保持这些疫苗接种低温的最佳方法。

在运输疫苗等对热敏感的保健食品时，我们提供装有冰袋的保温箱，以补偿与外界的热交换。

市场驱动力可能是需要温控冷藏托运人在全球范围内运输高质量的 COVID-19 疫苗。 例如，辉瑞注射剂需要在-70°C下长期储存，而Moderna注射剂需要在-20°C下长期储存。

COVID-19 疫苗接种是帮助遏制 COVID-19 大流行的重要预防措施。 随着疫苗接种活动的普及和疫苗生产效率的提高，预计对恆温箱的需求将会增加。 行业进入者正在巩固其在全球恆温疫苗盒市场的地位。

内容

第 1 章全球疫苗恆温箱市场研究方法和范围

• 调查方法
• 调查目的和范围

第 2 章全球疫苗恆温箱市场 - 市场定义和概述

第 3 章全球疫苗恆温器市场-执行摘要

• 按产品细分的市场
• 按材料细分的市场
• 按地区划分的市场细分

第 4 章全球疫苗恆温器市场 - 市场动态

• 市场影响因素
  • 司机
    • 为到达疫苗的最后一英里，对经济型冷链解决方案的需求不断增长，这推动了恆温箱的发展
  • 约束因素
    • 不完善的库存管理系统抑制了疫苗恆温槽的市场
  • 商机
  • 影响分析

第五章全球疫苗恆温箱市场-行业分析

• 波特的五力分析
• 供应链分析
• 定价分析
• 监管分析

第 6 章全球疫苗恆温器市场 - COVID-19 分析

• COVID-19 市场分析
  • COVID-19 之前的市场情景
  • COVID-19 的当前市场情景
  • COVID-19 后或未来情景
• COVID-19 期间的价格动态
• 供需范围
• 大流行期间与市场相关的政府举措
• 製造商的战略举措
• 总结

第 7 章全球疫苗恆温器市场 - 按产品分类

• 近程
  <5 升
  • 5-15 升
  • 15-25 升
• 远程
  • 5-15 升
  • 15-25 升

第 8 章全球疫苗恆温器市场 - 按材料分类

• 聚氨酯
• 聚丙烯
• 聚乙烯
• 聚苯乙烯
• 其他

第 9 章按地区分列的全球疫苗恆温器市场

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 中东和非洲

第 10 章等温疫苗容器的全球市场 - 竞争格局

• 竞争场景
• 市场分析/份额分析
• 併购分析

第 11 章全球疫苗恆温器市场-公司概况

• B Medical Systems
  • 公司概况
  • 最终用户的产品组合和描述
  • 主要亮点
  • 财务摘要
• BLOWKINGS India
• Sonoco ThermoSafe
• Termo-Kont MK LLC
• AOV International LLP
• Apex International
• PHC Holdings Corporation
• Tempack
• Tecnisample SL
• Nilkamal Material Handling

第12章 重要考察

第13章 DataM

Market Overview

The global isothermal boxes for vaccine market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 7.0% within the forecast period (2022-2029).

Immunizations are kept chilled during shipment using cold boxes and miniature antibody transporters. Isothermal boxes are the superset of cold boxes and vaccination carriers. Immunization transporters offer similar properties as cold boxes, except they have a smaller volume.

Based on the material, isothermal boxes for the vaccine market can be classified as polyurethane, polypropylene, polyethylene, polystyrene and others. A material type that has many different applications is polyurethane. Polyols and diisocyanates react to produce polyurethane foam. High-density polyurethane foam with two aluminized layers molded and linked with enough force to provide outstanding hardness makes up isothermal packing.

For the vaccination sector, there are also long-range and short-range isothermal boxes. The two sizes of long-range isothermal vaccine containers are 5-15 liters and 15-25 liters. Short-range isothermal boxes in the vaccine sector are divided into 15 and 25 liters, 5 and 15 liters and under 5 liters.

Market Dynamics

Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes.

Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes

Vaccines are one of the most significant successes in world health and development. Vaccines have successfully decreased the scourge of diseases like polio, measles and smallpox for over two centuries, allowing children to grow healthy and happy. According to UNICEF, even before COVID-19 arrived, they saved more than five lives every minute, averting up to three million fatalities yearly.

Children can walk, play and learn thanks to global immunization initiatives. Vaccinated children perform better in school, resulting in economic benefits for their communities. Vaccines are now considered one of the most cost-effective ways to improve global welfare.

However, improper and incompetent vaccine supply for the last-mile reach is one of the top threats to public health. According to UNICEF, some 20 million children miss out on life-saving vaccines annually. The poorest and most marginalized children who often need vaccines are the least likely to get them. Therefore, UNICEF and their partners harness solar power, mobile technology and telemetrics to assure vaccines reach all children without losing their effectiveness from vulnerability to extreme heat or cold weather conditions.

A solitary well-being specialist can convey isothermal boxes for the vaccine, particularly antibody transporters, via vehicle or walking to an effort meeting because of their small size. Moreover, isothermal antibodies also move immunizations from essential medical care habitats to transitional immunization stores.

Poor administration of the inventory network is restraining the isothermal boxes for the vaccine market

The global isothermal boxes for vaccines market is projected to be hampered by poor supply chain management. The improper use of coolant packs and the selection of inappropriate isothermal boxes, among other things, are examples of poor management. A slew of difficulties is hampering cold chain logistics management.

Despite the great demand, only a few logistics businesses can meet the difficulty of delivering isothermal vaccination and other highly regulated pharmaceutical products. In U.S., for example, 78 percent of cold storage warehouses are over two decades old and unfit for modern operational needs.

Inefficiencies in fleet management are another issue that must be addressed. Refrigerators and vehicles frequently fail. Ordering extra parts and performing routine maintenance might slow down operations. At the same time, a lack of cold chain insight into fleet movements can cause shipping delays and instances where imported products wait at ports of entry for an extended period.

Furthermore, transporting materials that require exact temperature and humidity conditions is costly. However, with limited sight and control, even little changes in the transportation environment might result in significant losses. The stakes are particularly higher when it comes to high-value pharmaceuticals.

As a result, vaccinations will likely lose efficacy if the supply chain is not kept within the proper temperature range. Significant efforts are being made to bring freeze-safe isothermal vaccination packaging to market.

COVID-19 Impact Analysis

The worldwide health crisis brought on by the COVID-19 pandemic has boosted demand for isothermal vaccine transport boxes to combat the SARS-CoV-2 virus. All heat-sensitive vaccines have storage temperature ranges controlled using active or passive cold manufacturing methods, but the earliest COVID-19 vaccines must be stored and transported between -90 and -60 °C.

Traditional eutectic plates for the -25/-15 °C range cannot meet the temperature requirement since they do not have melting temperatures near -70 °C. With a sublimation enthalpy of 573 kJ.kg-1 (25,2 kJ.mol-1) at -78.5 °C, dry ice is the best approach to keep these vaccinations cold.

Insulated boxes are supplied with a cold source to compensate for thermal exchanges with the outside when transporting vaccinations and other heat-sensitive health items.

The market is likely driven by the requirement for temperature-controlled thermal shippers to transfer high-quality COVID-19 vaccines globally. For example, the Pfizer jab requires long-term storage at -70°C, but the Moderna jab requires long-term storage at -20°C.

COVID-19 immunization is an important preventative step that can assist in bringing the COVID-19 pandemic to a stop. The need for isothermal boxes is predicted to rise as vaccination campaigns become widespread and vaccine manufacturing becomes more efficient. The industry's participants are strengthening their position in the worldwide isothermal vaccine boxes market.

Segment Analysis

The global isothermal boxes for vaccine market is segmented by product, material and region.

Long range vaccine boxes are portable with reduced capacity for a longer travel time range of 24 hours to 8 days

Based on product, the global isothermal boxes for vaccine market is segmented into short range and long range. The long range holds a major share in isothermal boxes for the vaccine market. Vaccines are kept chilled throughout shipment using cold boxes and miniature vaccine carriers. Isothermal boxes are defined as the superset of cold boxes and vaccine carriers. Vaccine carriers are similar to cold boxes, except that they have a lower volume. Because both cold boxes and vaccine carriers are passive carriers, coolant packs that offer warmth for a set amount of time are required.

Vaccine carriers are portable due to their reduced capacity. They're used to deliver vaccinations and diluents from hospitals to rural locations where ice and refrigeration aren't available.

Depending on their use, cold boxes can last from a few hours to many days. Vaccines are not time-limited, but they must be kept between 2 and 8 degrees Celsius from the time they are created until they are administered.

In comparison to any other type of vaccine packaging, the isothermal container constructed of expanded polyethylene and polypropylene is in high demand. It provides good thermal insulation. Vacuum Insulation Panels, dry ice or PCM-filled cooling plates can keep the temperature steady for hours or days.

Geographical Analysis

Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others

The Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others.

Furthermore, due to rising vaccination awareness and increased immunization programs, Asia-Pacific presents lucrative prospects for isothermal boxes key vaccine industry players to grow in the forecast period. The market expansion in this region may be attributed to an increase in vaccination demand, senior population, awareness and continued government support for vaccine development.

All countries and territories in Asia-Pacific have established vaccination programs that include a minimum number of routine vaccines (such as those for polio, diphtheria, tetanus, pertussis and measles); additional vaccines (such as those for pneumococcus, rotavirus and human papillomavirus) are added at the national or subnational level based on local morbidity, mortality and cost-effectiveness analysis.

In addition, In 2019, the overall vaccination of children against pertussis (provided through combined vaccines containing diphtheria and tetanus), measles and hepatitis B was high in most Asia-Pacific countries. While vaccination rates have plateaued at a high level in many countries and territories in Asia-Pacific, some countries with historically low rates have made substantial progress in recent years.

Vaccine safety surveillance is improving globally, with 73% and 63% of nations reporting adverse events following immunization in the WHO areas of South East Asia and the Western Pacific, respectively. Thus improving vaccination percentage in the region has created a huge market share for isothermal boxes for vaccine storage in the Asia-Pacific region.

Competitive Landscape

The global isothermal boxes for vaccine market is highly competitive with local and global key players. The key players contributing to the market's growth are B Medical Systems, BLOWKINGS India, Sonoco ThermoSafe, Termo-Kont MK LLC, AOV International LLP, Apex International, PHC Holdings Corporation, Tempack, Tecnisample SL, Nilkamal Material Handling, Isonova among others.

The major companies are adopting several growth strategies, such as product launches, acquisitions and collaborations, contributing to the global growth of the isothermal boxes for vaccine market.

• On February 4, 2021, The North American division of PHC Corporation partnered with Follett Products, LLC (Follett), a division of The Middleby Corporation, for the sales of the PHCbi series of ultra-low temperature (ULT) freezers, pharmaceutical-grade refrigerators and biological freezers. Both the company's healthcare clients are expected to benefit from this partnership.

B Medical Systems

Overview: B Medical Systems manufactures and distributes innovative solutions required to transport and store blood components, vaccines, laboratory specimens, etc. The company offers an end-to-end solution of refrigerated devices certified by the US FDA, EU MDR and WHO PQS. The company's portfolio includes laboratory refrigerators, medical-grade vaccine refrigerators, laboratory freezers, blood bank refrigerators, plasma freezers, contact shock freezers, ultra-low freezers and transport boxes. B Medical Systems offer storage and transportation products ranging from -80 °C to +4°C, which the Govt of Luxembourg is currently using for transporting COVID-19 vaccines.

Product Portfolio: VACCINE TRANSPORT BOX RCW1: The product is offered with the following specifications:

• Gross volume: 0.06 cu.ft. | 1.73 L
• Vaccine storage capacity: 0.04 cu.ft. | 1.04 L
• Certifications: WHO PQS E004/059
• Climate class: Hot zone (+43°C)
• Cold life at +43°C: 32h 06 min up to 10°C

Key Development

• On October 01, 2021, B Medical Systems completed its new factory extension spanning approximately 4500 square meters. The expansion project witnessed an investment of US$ 17.4 million (Euro 15 million), a part of which was funded by the Ministry of the Economy of Luxembourg due to the rising need for products to help combat the health crisis.

Why Purchase the Report?

• Visualize the global isothermal boxes for vaccine market segmentation by product, material and region, highlighting key commercial assets and players.
• Identify commercial opportunities in the isothermal boxes for vaccine market by analyzing trends and co-development deals.
• Excel data sheet with thousands of global isothermal boxes for vaccine market-level 4/5 segmentation points.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global isothermal boxes for vaccine market report would provide approximately 69 market data tables,70 figures and 214 pages.

Target Audience 2022

• Service Providers/ Buyers
• Residential
• Research Laboratory
• Restaurant Business
• Energy & Utilities Companies
• Distributors

Table of Contents

1. Global Isothermal Boxes For Vaccine Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Isothermal Boxes For Vaccine Market - Market Definition and Overview

3. Global Isothermal Boxes For Vaccine Market - Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Material
• 3.3. Market Snippet by Region

4. Global Isothermal Boxes For Vaccine Market-Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes
    • 4.1.1.2. XX
  • 4.1.2. Restraints
    • 4.1.2.1. Poor administration of the inventory network is restraining the isothermal boxes for the vaccine market
    • 4.1.2.2. XX
  • 4.1.3. Opportunity
    • 4.1.3.1. XX
  • 4.1.4. Impact Analysis

5. Global Isothermal Boxes For Vaccine Market - Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. Global Isothermal Boxes For Vaccine Market - COVID-19 Analysis

• 6.1. Analysis of COVID-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Isothermal Boxes For Vaccine Market - By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Short Range *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. < 5 liters
  • 7.2.4. 5 - 15 liters
  • 7.2.5. 15 - 25 liters
• 7.3. Long Range
  • 7.3.1. 5 - 15 liters
  • 7.3.2. 15 - 25 liters

8. Global Isothermal Boxes For Vaccine Market - By Material

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Material
• 8.2. Polyurethane *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Polypropylene
• 8.4. Polyethylene
• 8.5. Polystyrene
• 8.6. Others

9. Global Isothermal Boxes For Vaccine Market - By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. UK
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. South Korea
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material

10. Global Isothermal Boxes For Vaccine Market - Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Global Isothermal Boxes For Vaccine Market- Company Profiles

• 11.1. B Medical Systems *
  • 11.1.1. Company Overview
  • 11.1.2. End-User Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. BLOWKINGS India
• 11.3. Sonoco ThermoSafe
• 11.4. Termo-Kont MK LLC
• 11.5. AOV International LLP
• 11.6. Apex International
• 11.7. PHC Holdings Corporation
• 11.8. Tempack
• 11.9. Tecnisample SL
• 11.10. Nilkamal Material Handling

LIST NOT EXHAUSTIVE

12. Global Isothermal Boxes For Vaccine Market - Premium Insights

13. Global Isothermal Boxes For Vaccine Market - DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us